Sarepta Appoints Catherine Stehman-Breen Chief Medical Officer

Xconomy Boston — 

Catherine Stehman-Breen is moving to Sarepta Therapeutics (NASDAQ: SRPT) to become the Cambridge, MA, company’s chief medical officer. Stehman-Breen previously served as vice president of clinical development and regulatory affairs for Regeneron Pharmaceuticals (NASDAQ: REGN), a Tarrytown, NY, biotech. Before joining Regeneron in 2015, Stehman-Breen held several posts at Amgen (NASDAQ: AMGN).